Healthcare / Medical Care FacilitiesThailand
$5.95
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-225.3M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
52/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.2B
P/E
11.7x
↓EV/EBITDA
8.4x
↓ROE
18.2%
↑Gross Margin
33.0%
↓Debt/Equity
0.64
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+26.7%
FCF CAGR
—
FCF margin
-14.0%
FCF / Net income
-0.93x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.33B · net income $351.8M · FCF $-325.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.33B | $2.33B | $2.03B | $1.46B | $1.15B |
| Net Income | $351.8M | $351.8M | $278.8M | $92.9M | $115.7M |
| EBITDA | $626.5M | $626.5M | $532.7M | $273.4M | $237.5M |
| EPS | 0.50 | 0.50 | 0.40 | 0.14 | 0.18 |
| Gross Margin | 33.0% | 33.0% | 31.4% | 25.1% | 28.3% |
| Operating Margin | 19.7% | 19.7% | 18.8% | 10.5% | 13.8% |
| Net Margin | 15.1% | 15.1% | 13.7% | 6.4% | 10.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.64 | 0.64 | 0.59 | 1.15 | 0.87 |
| Current Ratio | 1.04 | 1.04 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-325.9M | $-325.9M | $186.6M | $-225.3M | $-120.3M |
| Returns | |||||
| ROE | 18.2% | 18.2% | 17.7% | 8.7% | 11.2% |
| Valuation | |||||
| P/E | 11.67 | 11.67 | 21.22 | 31.29 | 21.87 |
| EV/EBITDA | 8.44 | 8.44 | 12.76 | 14.48 | 14.11 |
| P/B | 2.17 | 2.17 | 3.76 | 2.65 | 2.40 |
| Growth & Yield | |||||
| Revenue Growth | 14.6% | 14.6% | 39.2% | 27.4% | — |
| EPS Growth | 26.3% | 26.3% | 185.6% | -21.1% | — |
| Dividend Yield | 1.2% | 1.2% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
1.8%
EPS terminal req.
$0.53
Spread vs growth
24.5%
5Y implied EPS CAGR
5.0%
EPS terminal req.
$0.64
Spread vs growth
21.3%
10Y implied EPS CAGR
7.5%
EPS terminal req.
$1.03
Spread vs growth
18.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-23.5%
Start / end P/E
20.0x → 11.9x
EPS bridge
0.40 → 0.50
Residual
-10.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.